0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Presidential Address | 
Ashby C. Moncure, MD
Arch Surg. 2001;136(4):376-382. doi:10.1001/archsurg.136.4.376.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Neurology
Original Investigation  | 
Impaired Cerebrovascular Reactivity in Multiple Sclerosis
Olga Marshall, MS; Hanzhang Lu, PhD; Jean-Christophe Brisset, PhD; et al.
JAMA Dermatology
Research Letter  | 
Risk for Nevus Transformation and Melanoma Proliferation and Invasion During Natalizumab Treatment:  Four Years of Dermoscopic Follow-up With Immunohistological Studies and Proliferation and Invasion Assays
Momen Pharaon, MD; Mélanie Tichet, MSc; Christine Lebrun-Frénay, MD, PhD; et al.
JAMA Neurology
Case Report/Case Series  | 
Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum
Yong Guo, MD, PhD; Vanda A. Lennon, MD, PhD; Bogdan F. Gh. Popescu, MD, PhD; et al.
JAMA Neurology
Viewpoint  | 
Inadequacy of Clinical Trial Designs and Data to Control for the Confounding Impact of Race/Ethnicity in Response to Treatment in Multiple Sclerosis
Jagannadha Avasarala, MD, PhD